related to Litigation · 18Boehringer Ingelheim → Aggrenox, Atrovent, Boehringer Ingelheim Pharmaceuticals, Chief Judge David, Combivent, Drug Administration, Herndon, Illinois, In August, In October, Inc, May, Micardis, On, Pradaxa, Southern District, The, US Food
related to 2016 – Sanofi asset swap · 17Boehringer Ingelheim → AMG, Amgen, As, BI, Boehringer, Boehringer Ingelheims Phase, Ceva Santé Animale, Eli Lilly's Elanco Animal, Health, In June, In October, In September, Merial, Sanofi, T-cell, The, US
related to 2018–onwards · 15Boehringer Ingelheim → Amal Therapeutics SA, Boehringer, Boehringer Ingelheim Pharmaceuticals, ICD Therapeutics, In, In April, In July, In March, Inc, OSE Immunotherapeutics, OSE's, OSE-172, September, Topas Therapeutics, ViraTherapeutics
related to Operational sites · 14Boehringer Ingelheim → Asia, Austria, Europe, Frankfurt, Germany, Ingelheim, Mainz, Molecular Pathology, North America, Rhein, The, The Research Institute, Their, Vienna
related to Ownership and leadership · 14Boehringer Ingelheim → Andreas Barner, As, Baumbach, BI, Board, CEO, CFO Hubertus, Chairman, Christian Boehringer, In, IPO, Johann, Managing Directors, Shareholders’ Committee Dr Heribert
related to Collaborative research and partnership with Google Quantum AI · 13Boehringer Ingelheim → Application Consortium, EFPIA, European Commission, Google, Google Quantum AI, InnoMed PredTox, Innovative Medicines Initiative, On January, One, Quantum Lab, Quantum Technology, QUTAC, The
related to Closure of Bedford plant · 11Boehringer Ingelheim → Bedford, Ben Venue, Ben Venue Laboratories, Drug Administration, Food, However, In, October, Ohio, The, US
related to overview · 10Boehringer Ingelheim → Biberach, Connecticut, Germany, Kobe, Milan, Over, Research, Ridgefield, The, Vienna
related to 2000–2016 · 9Boehringer Ingelheim → Actimis, Actimis Pharmaceuticals, AP768, Boehringer Ingelheim Shionogi Vetmedica, GmbH, In, In December, In June, STEAG
Key people · 6Boehringer Ingelheim → Armin Wiesler, Frank Hübler, Harsha Deshmukh, Michael Schmelmer (vice chairman), Paola Casarosa, Shashank Deshpande (chairman of the board)
